Other malignant lesions of the liver
Functional Imaging in Oncology: Clinical Applications - Volume 2, Page: 1025-1064
2014
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
Malignant lesions of the liver, other than hepatocellular carcinoma (HCC) and metastases, are uncommon conditions, whose main one is represented by cholangiocellular carcinoma (CHC). Other rare lesions are vascular tumors (angiosarcoma and epithelioid hemangioendothelioma) and cystic tumors (cystadenoma/cystadenocarcinoma). Exposure to different risk factors accounts for a variable incidence of the diseases in the different geographic areas, especially for CHC. Imaging findings are strictly related to the pathological composition of the tumors, whose knowledge is fundamental in order to make a correct diagnosis. Moreover, the different imaging techniques can offer specific information, able to suggest the correct diagnosis. However, due to the relative rarity of most of these lesions, imaging has been focused most on detection and characterization, especially with functional imaging, limited to characterization, not to therapy monitoring.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84956710428&origin=inward; http://dx.doi.org/10.1007/978-3-642-40582-2_19; https://link.springer.com/10.1007/978-3-642-40582-2_19; https://dx.doi.org/10.1007/978-3-642-40582-2_19; https://link.springer.com/chapter/10.1007/978-3-642-40582-2_19
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know